Through innovative integration of a continuous glucose monitoring device and an insulin pump, a recent FDA-approved device called a bio artificial pancreas from Medtronic has been shown to improve the insulin treatment in T1DM[18]. This evidence concerns the gene INS and type 1 diabetes mellitus.